『Inside the Industry with Kim Laipple: Ep 1 Trio Pharma|Patrick Doyle』のカバーアート

Inside the Industry with Kim Laipple: Ep 1 Trio Pharma|Patrick Doyle

Inside the Industry with Kim Laipple: Ep 1 Trio Pharma|Patrick Doyle

無料で聴く

ポッドキャストの詳細を見る
Episode 1: Patrick Doyle, CEO of Trio PharmaceuticalsEpisode Description

What does it really take to bring breakthrough therapies from the lab to patients?

In the premiere episode of Inside the Industry, Kim Laipple sits down with Patrick Doyle, CEO of Trio Pharmaceuticals, to discuss the realities of biotech leadership, drug development, fundraising, and innovation.

With more than 25 years of experience spanning startups and global pharmaceutical leaders including Novo Nordisk and Roche, Patrick shares the pivotal moments that shaped his career, lessons learned through both success and failure, and why the best biotech leaders let data—not emotion—guide critical decisions.

The conversation explores the challenges of raising capital in today's market, the importance of experienced leadership teams, Trio's innovative Trailbody™ platform for targeted cancer therapies, and emerging technologies such as artificial intelligence and synthetic organ development that could reshape the future of medicine.

Whether you're a biotech executive, scientist, investor, entrepreneur, or simply passionate about healthcare innovation, this episode offers valuable insights into the people and decisions driving the life sciences industry forward.

In This Episode
  • Patrick's journey from scientist to biotech CEO
  • Leadership lessons from Novo Nordisk and Roche
  • Navigating setbacks in drug development
  • What investors look for in biotech companies
  • How Trio's Trailbody™ platform targets cancer cells
  • Why "kill early" is a critical biotech philosophy
  • AI's role in drug discovery and development
  • The future of regenerative medicine and synthetic organs
  • Building resilient teams and making data-driven decisions
About Patrick Doyle

Patrick Doyle is the CEO of Trio Pharmaceuticals. Throughout his career, he has helped build and lead multiple biotechnology companies, raised more than $300 million across seven ventures, and contributed to four successful acquisitions. Prior to Trio, he served in executive leadership roles at K Bio, Stellexis Bioscience, Novo Nordisk, and Roche.

Connect

Trio Pharmaceuticals: https://www.triopharmaceuticals.com

Patrick Doyle: https://www.linkedin.com/in/pj-doyle/

Scientific Search: https://www.scientificsearch.com

If you enjoyed this episode, be sure to subscribe, leave a review, and share it with colleagues in biotech, pharmaceuticals, and healthcare innovation.

#InsideTheIndustry #Biotech #LifeSciences #Pharmaceuticals #DrugDevelopment #Biotechnology #Leadership #CancerResearch #HealthcareInnovation #ScientificSearch

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません